Myeloproliferative disease complicated by megaloblastic anemia and hyperuricemia.
D000748:Anemia, Macrocytic / Q000150:complications*; D001769:Blood; D001778:Blood Coagulation Disorders / Q000209:etiology; D002066:Busulfan / Q000627:therapeutic use; D057487:Enzyme Therapy; D004844:Epistaxis / Q000209:etiology; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use*; D005494:Folic Acid Deficiency / Q000209:etiology*; D006454:Hemoglobins; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D008875:Middle Aged; D011086:Polycythemia / Q000209:etiology; D055728:Primary Myelofibrosis / Q000150:complications*; D013921:Thrombocytopenia; D014527:Uric Acid / Q000378:metabolism*
D006454:Hemoglobins; D014527:Uric Acid; D005492:Folic Acid; D007501:Iron; D002066:Busulfan
Br J Haematol. 1958 Oct;4(4):375-89
13596521
Br Med J. 1964 Mar 14;1(5384):671-2
14096462
Blood. 1951 Apr;6(4):372-5
14820991
Proc R Soc Med. 1958 Sep;51(9):757-63
13591299